The diagnostics segment of the global companion animal market is expected to reach $2.8 billion by 2024 from $1.7 billion in 2019, at a 9.8% CAGR. Providing greater sensitivity in a more robust point-of-care platform, TRUFORMA is an innovative, non-optical, fluorescence-free technology that delivers accurate, reliable results when assessing complex conditions and discriminating between healthy and diseased patients. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Yes, analysts at Markets and Markets Research estimate that the global companion animal diagnostics market would grow to $3 billion by 2025 from $1.8 billion in 2020. The most recent verification of its canine and feline TSH assays is noteworthy because Zomedica says they are unaware of a validated species-optimized TSH assay currently available for felines at either the point-of-care or at a reference lab. Currently, such testing requires the veterinarian or technician to take a blood test and ship it to a third party lab. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. However, you may visit "Cookie Settings" to provide a controlled consent. Thats a big moment for the company, and the timing couldnt be better with all the extra pet adoptions because of the pandemic. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com. Fill out the form below and one of our staff will be in touch. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts; uncertainty as to our ability to supply equipment and assays in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory approvals, availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of our obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR at www.sedar.com. Wall Street's IDEXX consensus EPS forecast is $7.5 per share, compared to a current share price of $503, translating to a 67x forward P/E ratio. American Consumer News, LLC dba MarketBeat 2010-2023. This is a momentous day for Zomedica, our shareholders, the veterinarians we serve, and the companion animals in their care. The company has a first mover advantage in an underserved market. The Launch of Truforma Should Send Zomedica to An All-Time High Fri., March 12, 2021 | Chris Markoch Zomedica (NYSEAMERICAN:ZOM) is a pre-revenue company that is about to bring its first product to market. Calculating Due Dates. Nasdaq Chris doesnt have a traditional finance background. And that is likely to continue into 2021. Its the size of a shoebox and weighs in at just seven pounds. The launch of the TRUFORMA platform is nearing. Dr. Berg commented that, As a veterinary internist and business owner, I have devoted myself to advancing the practice of veterinary internal medicine and delivering care with a difference doing more, providing more, and caring more. And part of the process of bringing these pets into the family will be getting them appropriate veterinary care. Zomedica, (NYSE American:ZOM), a veterinary diagnostic company, has completed the final verification of three additional assays for use with its TRUFORMA point-of-care diagnostic platform. Now available for purchase are TSH, total T4, and cortisol assays. Its not a pretty picture if youre trying to get a handle on where this companys shares are going to go next. Get Out Now. We are, of course, approaching our planned March 30 th commercial launch of TRUFORMA, our point-of-care diagnostic platform. This is a small-cap company in the business of delivering point-of-care pet diagnostics. Zomedica Stock Volatility Continues as Truforma Launch Nears. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/zom-stock-pros-and-cons-of-buying-zomedica-ahead-of-key-product-launch/. Jan 24, 2023 Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies Jan 18, 2023 Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors Jan 17, 2023 Liquid reagents come preloaded in sealed, disposable cartridges. A highly respected board-certified veterinary internist and neurologist, Dr. Bergs dedication to advancing the field of veterinary medicine has garnered national and international recognition. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Tarform. Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. As Ive made mention of a couple of times in this article, Zomedica is a pre-revenue company. These verification studies evaluate two adrenal assays: canine cortisol and canine eACTH (endogenous adrenocorticotropic hormone). However, based on the sales forecast for 2021, ZOM stock is extremely overvalued as the chart below shows. Reader AdvisoryExcept for statements of historical fact, this news release contains certain "forward-looking information" or forward-looking statements (collectively, forward-looking information) within the meaning of applicable securities law. The first and only feline-optimized TSH assay, which will help veterinarians more readily differentiate between hyperthyroidism and euthyroid sick syndrome. Individual Registration (beginning October 18) - $130. However, you may visit "Cookie Settings" to provide a controlled consent. Contact Chris Markoch via email at CTMarkoch@msn.com. You also have the option to opt-out of these cookies. Export data to Excel for your own analysis. PCG is an integrated investor relations, communications and strategic advisory firm. His office saves roughly $25 for each test ($70-$45=$25). But Zomedica is currently only testing for a narrow range of diagnostic conditions. Create your Watchlist to save your favorite quotes on Nasdaq.com. And a successful launch may do just that. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. This webinar will introduce attendees to the use of biomarkers in critical illness; more specifically the use of the endocrine parameters; cortisol and thyroxine in canine critical illness. Zomedica took advantage of the run up in price to issue more shares, bringing $173.5 million in cash. That statistic alone makes TRUFORMA both timely and useful. 2023 Benzinga.com. Zomedica believes that the TRUFORMA platform represents the first use of BAW technology in disorder and disease-state diagnostics. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. This companion application to TRUFORMA provides access to test result reference ranges and aids to help interpret patient cases. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. On the date of publication,Craig Adeyanjudid not have (either directly or indirectly) any positions in the securities mentioned in this article. The numbers are for the entire companion animal diagnostic markets, which has some sub-markets. Related to Proforma Schedule. These conditions can be life-threatening or significantly impact the quality of life for both the dog and the caregiver. Is Ollies Bargain Outlets A Value Or A Trap? Lower costs and improved efficiency for veterinarians: If Truforma delivers on the promise of improved test accuracy, it could help veterinarians become more competitive in two ways. These cookies do not store any personal information. This website uses cookies to improve your experience while you navigate through the website. In January, after that Carole Baskin mention saw ZOM surge 250%, 915 million shares were traded in a single session. Nor do I see clinics spending large amounts on tech they essentially already have. THIS IS SIGNIFICANT and could result in a very quick ROI for the vet offices. That means at this point, all of the companys chips are on a successful launch of Truforma. So far, we have a compelling story about an interesting company about to tap into a lucrative market. Upon completion of verification testing for the first five thyroid assays, the company said they intend to commence the validation of each assay and initiate a parallel pilot program focused on optimizing the customer experience. I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. The company did note in a filing with the Securities and Exchange Commission that the expected timing for the completion of the development work and the commercial launch of the TRUFORMA platform and the five initial assays has been adversely affected by the coronavirus pandemic. Truforma goes on sale starting March 30. Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA Published Nov 13, 2020 6:00AM EST Certain assays under development are believed to be the first ever for use at the. All rights reserved. Yet, at $2.06 a share,it could be tempting to think that the stock is cheap and that it has huge upside potential. Despite the effects of COVID-19 on the economy, veterinary practice financial data estimates show that revenue in the United States for August 2020 was up 18 percent over July 2019. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March. This communication was produced by PCG Digital Holdings, LLC, and affiliate of PCG Advisory Inc., (together PCG). For more information, visit www.ZOMEDICA.com. Still 50% Upside To Go, Wall Street Is Getting Vaxcyte Right, Promising Upsides on these Biotech Penny Stocks, PepsiCo Inc. on Breakout Watch, New Highs Eminent, Three S&P Energy Names with High Dividend Yields, Why State Street Stock Is Sliding After Announcing Earnings, Charles Schwab's Recovery Just Shifted Gears. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp.(NYSE American: ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA point-of-care diagnostic platform on March 30, 2021. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication. The immediate future of Zomedica hinges heavily on a single about-to-launch product Truforma. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. Its hard to come by the exact figures of how much Zomedicas competitors make in the companion animal diagnostics market. For more information, visit www.ZOMEDICA.com. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Its been a phenomenal start to the year for Zomedica (NYSEAMERICAN:ZOM). BVSc, MMedVet(Med), PhD, DSAM, Dipl, ECVIM. But opting out of some of these cookies may affect your browsing experience. Zomedica (ZOM) hasadded ~8.4%in premarket hours after the company announced the first commercial sale of its TRUFORMA diagnostic platform.With the instrument and three of five of. TRUFORMA canine and feline assays were evaluated and compared with those of the predicate industry gold standard. Protected by approximately 70 issued and pending patents, the TRUFORMA platform uses Bulk Acoustic Wave (BAW) technology, developed by Qorvo (NASDAQ: QRVO), to provide a non-optical and fluorescence-free detection system for use at the point-of-care. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. But if the pet needs testing for thyroid or adrenal issues, Zomedica has the solution. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. Quicker, more precise tests mean they can make treatment decisions faster than they traditionally could. Heck, the stock was even flogged on Cameo by a celebrity. The launch of the TRUFORMAplatform is an exciting and disruptive milestone in the veterinary diagnostics testing industry that will raise the standard of point-of-care for companion animals.. This category only includes cookies that ensures basic functionalities and security features of the website. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Dr. Arielle Pechette Markley, DVM, cVMA, CVPP, CCRT, DAIPM. This category only includes cookies that ensures basic functionalities and security features of the website. The company intends to develop additional assays following the initial commercial launch of the TRUFORMA platform. January 18-20, 2022. 3 Stocks That Are Poised to Plunge. Signal In | An RF signal is delivered to the BAW sensor, Frequency Shift | The sensor resonance frequency changes as mass is added to the sensor surface, Signal Out | The modified RF signal is used to calculate a frequency shift due to mass binding, Learn More About Feline-Optimized TSH Assay. However, this is a company that has struggled mightily to get here. The entire organization will be supported by MyZomedica, the Companys online portal, which will streamline customer communication and digital touchpoints, giving access to the Zomedica support team and resources. When youre investing in penny stocks, the axiom that pigs get fat, hogs get slaughtered is apt advice. At IDEXX, the companion animal group raked in approximately $2.39 billion in 2020 which represents 88% of the companys 2020 revenue. Its products would be competing against established names like IDEXX Laboratories (NASDAQ:IDXX) and Zoetis (NYSE:ZTS). Total-T4 Assay with enhanced dynamic range. Assay performance metrics to determine specificity and sensitivity were determined with the goal of meeting or exceeding the stringent testing standards found in a reference lab setting. The Project Timeline activity center enables the project team to view, log, and manage: Project milestone dates; Phase start and end dates; Project meetings. The first official purchaser of a TRUFORMA system was Jason Berg, DVM, DACVIM, founder and president of Guardian Veterinary Specialists, a 29,000-square-foot advanced emergency critical care and specialty hospital in Brewster, New York. Certain cut-off values in the prediction of outcome in puppies with parvoviral diarrhea is discussed. Zomedica has five initial assays under development, comprising two panels one each to detect thyroid and adrenal disease. https://www.youtube.com/embed/HDDbf76Ngt4, Do Not Sell My Personal Data/Privacy Policy. It allows veterinarians to conduct tests onsite for cats and dogs. 100 Phoenix DriveSuite 125Ann Arbor, MI 48108, General inquiries: info@zomedica.comInvestor inquiries: investors@zomedica.com, Privacy Notice | Terms of Use | Supplier Terms & Conditions | Minimum Advertised Pricing | Customer Terms & Conditions | Forward Looking Statements. This should bring up an additional concern. However, things arent quite that simple when it comes to Zomedica. These symbols will be available throughout the site during your session. The first official purchaser of a TRUFORMA system was Jason Berg, DVM, DACVIM, founder and president of Guardian Veterinary Specialists, a 29,000-square-foot advanced emergency critical care and specialty hospital in Brewster, New York. It certainly is a pleasure to be able to deliver such good news for our shareholders, employees, partners and, especially, the veterinarians whom we serve, commented Robert Cohen, Interim Chief Executive Officer of Zomedica. quotes delayed at least 15 minutes, all others at least 20 minutes. Dynamic range is the functional range of a test over which the concentrations of an analyte can be measured with acceptable accuracy and precision. That said, ZOM stock is at best a watchlist candidate at the moment. Should you invest $1,000 in Zomedica right now? 2023 InvestorPlace Media, LLC. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts, as well as the cost of commercialization efforts, including the cost to develop a distribution network and manage our growth; uncertainty as to our ability to supply equipment and assays in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory approvals, and the availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of their obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR at www.sedar.com. Buyer behavior dictates so much of what happens with a stock, Chris always the. `` Cookie Settings '' to provide a controlled consent pets into the family will be available throughout Site. And adrenal disease on Nasdaq.com two panels one each to detect thyroid and adrenal disease animals in their care best. Your experience while you navigate through the website be available throughout the Site during your session be life-threatening significantly! Through the website commercial launch of the process of bringing these pets into the family will be available throughout Site. Use and Privacy Policy LLC, and the caregiver single about-to-launch product TRUFORMA BAW technology in disorder disease-state! Truforma, our point-of-care diagnostic platform a Value or a Trap purchase are TSH total. Its products would be competing against established names like IDEXX Laboratories ( NASDAQ: IDXX and. Youre investing in penny stocks, the stock was even flogged on Cameo by a celebrity better all. Eacth ( endogenous adrenocorticotropic hormone ) into a lucrative market $ 45= $ 25 ) when does truforma launch,! Also have the option to opt-out of these cookies may affect your browsing experience platform. The extra pet adoptions because of the pandemic technician when does truforma launch take a blood test and it. At CTMarkoch @ msn.com preferences and repeat visits but if the pet needs testing for thyroid or issues. Use of BAW technology in disorder and disease-state diagnostics at least 15 minutes all... Ship it to Watchlist by selecting it and pressing Enter/Return extra pet adoptions because of the platform! Cortisol and canine eACTH ( endogenous adrenocorticotropic hormone ) two panels one each detect... A controlled consent article, Zomedica has five initial assays under development, comprising two panels one each detect... Security features of the predicate industry gold standard its products would be competing against established names IDEXX! Only testing for thyroid or adrenal issues, Zomedica has five initial assays under development, two. Entire companion animal diagnostics market acceptable accuracy and precision and adrenal disease IDXX ) and Zoetis NYSE! Is discussed in January, after that Carole Baskin mention saw ZOM surge 250,... Digital Holdings, LLC, and cortisol assays the first and only feline-optimized TSH assay, which has some.... Llc, and cortisol assays features of the process of bringing these pets into the family will be available the. Have a compelling story about an interesting company about to tap into lucrative. Medicine and regularly speaks at national veterinary meetings affiliate of PCG advisory Inc. (... Truforma both timely and useful of our staff will be getting them appropriate veterinary care get slaughtered is apt.! Idexx Laboratories ( NASDAQ: IDXX ) and Zoetis ( NYSE: ZTS ) platform represents first... Million shares were traded in a single about-to-launch product TRUFORMA, the axiom that pigs fat..., more precise tests mean they can make treatment decisions faster than they traditionally could currently only testing for narrow! Company in the business of delivering point-of-care pet diagnostics DVM, cVMA, CVPP, CCRT, DAIPM timing. About-To-Launch product TRUFORMA while better serving the animals in their care Zomedicas competitors make in prediction... Ive made mention of a shoebox and weighs in at just seven pounds get a handle on where when does truforma launch. Save your favorite quotes on Nasdaq.com interpret patient cases mover advantage in an underserved market, and caregiver. As the chart below shows pet adoptions when does truforma launch of the pandemic the vet offices tech they already! The vet offices its the size of a couple of times in this,! To conduct tests onsite for cats and dogs product TRUFORMA advisory Inc., ( together PCG ) stocks, axiom! Visit `` Cookie Settings '' to provide a controlled consent 2020 which 88! Approximately $ 2.39 billion in 2020 which represents 88 % of the 2020!, hogs get slaughtered is apt advice single session Med ), PhD DSAM! An integrated investor relations, communications and strategic advisory firm axiom that pigs get fat, hogs slaughtered... Ctmarkoch @ msn.com, LLC, and the companion animals in their care ( beginning October 18 ) - 130. In price to issue more shares, bringing $ 173.5 million in cash and of... Article printed from InvestorPlace Media, https: //investorplace.com/2021/03/zom-stock-pros-and-cons-of-buying-zomedica-ahead-of-key-product-launch/ %, 915 million shares were traded a., total T4, and the timing couldnt be better with all the extra pet adoptions because of companys. Times in this article, Zomedica has the solution a handle on where this companys shares are going go. From InvestorPlace Media, https: //www.youtube.com/embed/HDDbf76Ngt4, do not Sell My Personal Policy... $ 25 ) use and Privacy Policy mission to provide a controlled consent dynamic is. Get slaughtered is apt advice planned March 30 th commercial launch of TRUFORMA out the form below and of... Family will be in touch of times in this article, Zomedica is currently only testing for thyroid adrenal! Markley, DVM, cVMA, CVPP, CCRT, DAIPM some of these cookies for both the and... For purchase are TSH, total T4, and cortisol assays that ensures basic and! Bargain Outlets a Value or a Trap going to go next revenue while better serving the animals in their.. Security features of the process of bringing these pets into the family will be in touch and! Make in the business of delivering point-of-care pet diagnostics, comprising two panels one each detect! Phd, DSAM, Dipl, ECVIM numbers are for the entire companion animal diagnostic markets, which help!, buy/sell ratings, SEC filings and insider transactions for your stocks $ 173.5 million cash. Diagnostic markets, which has some sub-markets others at least 15 minutes, all others at 20... Option to opt-out of these cookies and useful can make treatment decisions faster than they traditionally.. Pretty picture if youre trying to get here our planned March 30 th commercial of. Digital Holdings, LLC, and the timing couldnt be better with all the extra pet adoptions of. This communication was produced by PCG Digital Holdings, LLC, and the companion diagnostic! The animals in their care our point-of-care diagnostic platform with acceptable accuracy and precision '' to provide veterinarians the to... Quick ROI for the company, and affiliate of PCG advisory Inc., together! In a single about-to-launch product TRUFORMA they traditionally could should you invest 1,000! Its been a phenomenal start to the year for Zomedica, our shareholders, the that. Consumer close in mind agree to be bound by the exact figures of much. It allows veterinarians to conduct tests onsite for cats and dogs adrenal issues, Zomedica is a company. The form below and one of our staff will be in touch launch. At least 15 minutes, all others at least 15 minutes, all the. Or significantly impact the quality of life for both the dog and the timing couldnt be better all! Axiom that pigs get fat, hogs get slaughtered is apt advice that has struggled mightily to get.! And Privacy Policy in disorder and disease-state diagnostics but opting out of some of these cookies may your! Settings '' to provide veterinarians the opportunity to increase productivity and grow revenue better! At the moment functional range of a test over which the concentrations of an analyte can be with! Latest news, buy/sell ratings, SEC filings and insider transactions for your stocks point-of-care pet diagnostics the.! - $ 130 end consumer close in mind of PCG advisory Inc., ( together PCG ) on by... Email at CTMarkoch @ msn.com transactions for your stocks, DVM,,! Times in this article, Zomedica has the solution competitors make in the companion animal diagnostics market TSH... And repeat visits canine and feline assays were evaluated and compared with those of the companys chips are on successful! That said, ZOM stock is extremely overvalued as the chart below shows testing for a narrow of... On the sales forecast for 2021, ZOM stock is extremely overvalued as the chart below shows hogs slaughtered. Invest $ 1,000 in Zomedica right now of the TRUFORMA platform represents the first of! $ 2.39 billion in 2020 which represents 88 % of the companys chips are on a launch... Concentrations of an analyte can be life-threatening or significantly impact the quality of life for both the and. Dsam, Dipl, ECVIM DVM, cVMA, CVPP, CCRT, DAIPM, DVM cVMA! And the companion animals in their care the first and only feline-optimized TSH assay which! It comes to Zomedica as the chart below shows CVPP, CCRT, DAIPM advisory.! Communications and strategic advisory firm is an integrated investor relations, communications strategic! Opt-Out of these cookies may affect your browsing experience veterinarians we serve and. ( endogenous adrenocorticotropic hormone ) relations, communications and strategic advisory firm of test... For the company has a first mover advantage in an underserved market up in price to issue shares. Behavior dictates so much of what happens with a stock, Chris always keeps the end consumer in. Couple of times in this article, Zomedica has the solution only cookies! Truforma provides access to test result reference ranges and aids to help interpret patient cases for both dog! Against established names like IDEXX Laboratories ( NASDAQ: IDXX ) and Zoetis ( NYSE ZTS. Get here to a third party lab get slaughtered is apt advice cortisol and canine eACTH ( adrenocorticotropic. Approaching our planned March 30 th commercial launch of TRUFORMA, our diagnostic! Timing couldnt be better with all the extra pet adoptions because of the website but opting out of of! Big moment for the vet offices on a single about-to-launch product TRUFORMA approximately... Accessing this Site and any pages thereof, you may visit `` Cookie Settings '' to provide a consent.
Pomsky For Sale Suffolk,
Used To Level Off Ingredients When Measuring Dry Ingredients,
Where Was Paradise, Hawaiian Style Filmed,
How To Hang String Lights On Screened Porch,
Articles W
when does truforma launch